Effects of Amaranthus caudatus l. extract and lovastatin on atherosclerosis in hypercholesterolemic rabbits

Journal of Medicinal Plants Research

Volumn 4, Issue 5, 2010, Pages 355-361

  Kabiri, Najmeh ^a   Asgary, Seddigheh ^b   Madani, Hossein ^b   Mahzouni, Parvin ^c  

^a UNIVERSITY OF ISFAHAN   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amaranthaceae; Amaranthus caudatus; Apolipoprotein; Atherosclerosis; CRP; Lipid; Ox LDL

Indexed keywords

AMARANTHUS CAUDATUS EXTRACT; APOLIPOPROTEIN A; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AMARANTHUS; AMARANTHUS CAUDATUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; RISK FACTOR;

AMARANTHACEAE; AMARANTHUS CAUDATUS; ORYCTOLAGUS CUNICULUS;

EID: 77950403576     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ahaneku JE, Nwosu CM, Farotimi A (2001). Lipid and lipoprotein cardiovascular risk factor responses to episodic academic stress. J. Health Sci. 47(3): 323-326.
2. Andrea YA, Plate JA (2002). Cholesterol-lowering effect of extruded amaranth (Amaranthus caudatus L.). Food Chem. 76: 1-6.
3. Berger A, Gremaud G, Baumgartner M, Rein D, Monnard I, Kratky E (2003). Cholesterol-lowering properties of amaranth grain and oil in hamsters. Int. J. Vitam. Nutr. Res. 73(1): 39-47.
4. Borradaile NM, Dreu LE, Barrett PH, Huff MW (2002). Inhibition of hepatocyte apoB secretion by naringenin: Enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters. J. Lipid Res. 43: 1544-1554.
5. Chekanov VS (2003). Low frequency electrical impulses reduce atherosclerosis in cholesterol fed rabbits. Med. 9(8): BR302-9
6. Danz RA, Lupton JR (1992). Physiology effects of dietary amaranth (Amaranthus cruentus) on rats. Cereal Foods World. 37(7): 489-494.
7. Elias-Scale SE, Kardys I, Oudkerk M, Hofman A, Witteman JC (2007). C-reactive protein is related to extent and progression of coronary and extra-coronary results from the Rotterdam study. Atherosclerosis (Epub ahead of print).
8. Francis FJ (1982). Anthocyanins as food colors. New York: Academic Press pp.181-207.
9. Guldiken S, Demir M, Anka E, Tugrul, A (2005). The level of serum high sensitive C-Reactive Protein in women with hyperthyroidism. J. Endocrinol. Metabolism 3: 85-88.
10. Hartke M (1987). DAB 9 kommentar,Stuttgart:Wissenschaftliche Verlagsgeselischaft mbH (Band 2). pp. 3515-3520.
11. Kadoshnikov SI, Kadoshnikova IG, Martirosyan DM (2005). Investigation of fractional composition of the protein in Amaranth. In book "Non-traditional natural resources, innovation technologies and products" Issue 12 Moscow, Russian Academy of Natural Sciences. Moscow pp. 81-104.
12. Kim HK, Kim MJ, Cho HY, Kim EK, Shin DH (2006). Antioxidative and anti-diabetic effect of amaranth in streptozotocin-induced diabetic rats. Cell Biochem. Funct. 24(3): 195-199.
13. Kim HK, Kim MJ, Shin DH (2006). Improvement of lipid profile by amaranth supplementation in streptozotocin-induced diabetic rats. Ann. Nutr. Metab. 50(3): 277-281
14. Martirosyan DM (2001). Amaranth as a nutritional supplement for the modern diet. Amaranth Legacy. USA 14:2-4.
15. Martirosyan DM (2003). Amaranth, quinoa and lentils as a source of modern diet and functional foods. In book: Non-traditional natural resources, innovation technologies and products Moscow, Russia, Russian Academy of Natural Sciences pp. 91-100.
16. Martirosyan DM, Miroshnichenko LA, Kulakova SN, Pogojeva AV, Zoloedov VI (2007). Amaranth oil application for coronary heart disease and hypertension. Lipids in health and disease. 6:1 doi: 10.1186/1476-511X-6-1.
17. Mertz DP (1980). "Atherosclerosis-index" (LDL/HDL): Risk indicator in lipid metabolism disorders. Med. Klin. 75(4):159-161
18. Nakamura YK, Read MH, Elias JW, Omaye ST (2006). Oxidation of serum low-density lipoprotein (LDL) and antioxidant status in young and elderly humans. Arch. Gerontol. Geriatr. 42(3): 265-276
19. Parmley WW (1997). Nonlipoprotein risk factors for coronary heart disease: Evaluation and management. Am. J. Med. 102:7-14.
20. Pergola C, Rossi A, Dugo P, Cuzzocrea S, Sautebin L (2006). Inhibition of nitric oxide biosynthesis by anthocyanin fraction of blackberry extract. Biol. Chem. M. 15:30-39.
21. Petry RD, Ortega GG, Silva WB (2001). Flavonoid content assay: Influence of the reagent concentration and reaction time on the spectrophotometric behavior of the aluminium chloride-flavonoid complex. Pharmazie 56(6): 465-470
22. Pogojeva AV, Gonor KV, Kulakova SN, Miroshnichenko LA, Martirosyan DM (2006). Effect of Amaranth oil on lipid profile of patients with cardiovascular diseases. In book functional foods for chronic diseases edited by: Martirosyan DM. Dallas. USA. pp. 35-45.
23. Qureshi AA, Qureshi N, Wright JK, Shen Z, Kramer G, Gapor A (1991). Lowering of serum cholesterol in hyperchlesterolemic humans by tocotrienols (palmvitee). Am. J. Clin. Nutr. 53: 1021-1026.
24. Quershi AA, Lehman JW, Peterson DM (1996). Amaranth and its oil inhibit cholesterol biosynthesis in 6-week old female chicken. J. Nutr. 126(8): 1972-1978.
25. Ross R (1999). Atherosclerosis: An inflammatory disease. N. Engl. J. Med. 340: 115-126.
26. Rasouli M, Kiasari MA, Mokhberi V (2006). The ratio apoB/apoA, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease. Clin. Chem. Lab Med. 44(8): 1015-1021.
27. Stulnig TM, Jurgens G, Chen Q, Moll D, Schonitzer D, Jarosch E, Wick G (1996). Properties of low density lipoproteins relevant to oxidative modifications change paradoxically during aging. Atherosclerosis. 126(1): 85-94.
28. Thakur N, Hayashi T, Iguchi A (2001). HMG-COA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxidase. Am. J. Physiol. 281: 75-83.
29. Yu SG, Thomas AM, Gapor A, Tan B, Qureshi N, Qureshi AA ( 2006). Dose-response impact of various tocotrienols on serum lipid parameters in 5-week-old female chickens. Lipids 41(5): 453-461